国立病院機構北海道医療センターは、札幌市西区山の手にある病院。2010年に国立病院機構西札幌病院と国立病院機構札幌南病院が統合して開院した。札幌市立山の手養護学校と渡り廊下で接続しており、通院・入院している児童に対応している。国立病院機構八雲病院の機能移転に伴い、新病棟を建設する予定である。

During the past decade, National Hokkaido Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Hokkaido Medical Center" are "COVID-19" (1 trials) and "Pneumonia, Bacterial" (1 trials). Many other conditions were trialed in "National Hokkaido Medical Center" in a lesser frequency.

Most popular intervention types in "National Hokkaido Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PF-07321332" (1 trials), "Placebo" (1 trials), "Ritonavir" (1 trials) and "ampicillin sodium/sulbactam sodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hokkaido Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Hokkaido Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Hokkaido Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hokkaido Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".